A critical advance in cancer investigation is emerging with the use of nanobodies to reactivate dysfunctional p53. This vital malignant inhibitor protein is frequently disabled in many forms of malignancies, resulting https://bookmarkrange.com/story23889865/vhh-fragments-revive-the-p53-protein-the-potential-hope-for-tumor-treatment